| Literature DB >> 21149565 |
Marco Geymonat1, Adonis Spanos, Sanne Jensen, Steven G Sedgwick.
Abstract
Lte1 is known as a regulator of mitotic progression in budding yeast. Here we demonstrate phosphorylation-dependent inhibition of polarized bud growth during G2/M by Lte1. Cla4 activity first localizes Lte1 to the polarity cap and thus specifically to the bud. This localization is a prerequisite for subsequent Clb-Cdk-dependent phosphorylation of Lte1 and its relocalization to the entire bud cortex. There, Lte1 interferes with activation of the small GTPases, Ras and Bud1. The inhibition of Bud1 prevents untimely polarization until mitosis is completed and Cdc14 phosphatase is released. Inhibition of Bud1 and Ras depends on Lte1's GEF-like domain, which unexpectedly inhibits these small G proteins. Thus, Lte1 has dual functions for regulation of mitotic progression: it both induces mitotic exit and prevents polarized growth during mitotic arrest, thereby coupling cell cycle progression and morphological development.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21149565 PMCID: PMC3002025 DOI: 10.1083/jcb.201005070
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 1.(a) Wild-type (WT; 15D) and lte1Δ cells (SY144) were arrested in nocodazole for 2 h; percentage of “hammerhead” phenotype is reported (n > 250). Bar, 5 µm. (b) Localization of Kel1-GFP in WT (SY159), lte1Δ (SY160), and lte1Δ cells complemented by Lte1, Lte1K1273E, or Lte1-Cdk arrested in nocodazole for 2 h. Bar, 5 µm. (c) WT (15D) and lte1Δ (SY144) cells were arrested in α-factor and released in medium containing nocodazole. At the indicated time, cells were harvested and Clb2 levels (top panel) and H1-associated kinase activity (bottom panel) were assayed. (d) Kel1-GFP localization in swe1Δ (MGY340) and swe1Δ lte1Δ (MGY341) cells arrested in nocodazole for 2 h. Bar, 5 µm.
Figure 2.Role of Kel1 in Lte1 localization and function. (a) Localization of Lte1-GFP and Kel1-CFP in cells (MGY305) overexpressing nondegradable Sic1 (top panels) and in cells treated with HU (bottom panels). DAPI was used to stain nuclei. Asterisk indicates actively growing bud; triangle indicates nongrowing bud. Bar, 5 µm. (b) WT (MGY369) and cla4Δ (MGY423) cells expressing Lte1-3HA were arrested by overexpression of nondegradable Sic1 (WT) or by HU treatment (WT and cla4Δ). Lte1-HA was visualized by Western blotting. (c) Localization of Lte1-GFP in WT (MGY593) and kel1Δ (MGY594) cells. Cells expressing Lte1-GFP from a MET3 promoter and Sic1 from the GAL1 promoter were cultivated in minimal medium without methionine and 2% sucrose as carbon source. α-Factor or galactose (2%) was added and Lte1 was observed after 2 h. DAPI was used to stain nuclei. Bar, 5 µm. (d) WT (MGY261 and MGY281) and kel1Δ (MGY479 and MGY480) cells expressing Lte1, Lte1-ProA, or Lte1-Cdk-ProA were arrested in HU and ProA-tagged proteins were immunoprecipitated. Immunoprecipitated Lte1-ProA and coimmunoprecipitated Ras2 proteins were detected (top and bottom panels, respectively). Relative amounts of Ras bound to each form of Lte1were quantified. (e) lte1Δ slk19Δ (MGY212) and lte1Δ slk19Δ kel1Δ (MGY 503) strains kept alive by a centromeric URA3-based plasmid expressing Lte1 were transformed with integrative plasmids expressing Lte1 and Lte1-Cdk. Serial dilutions of transformants were spotted on rich medium and 5-FOA–containing plates and cultivated at 30°C for 3 d.
Figure 3.Multi-step phosphorylation of Lte1. (a) Cells expressing Lte1-GFP and a degron form of Cla4-HA (MGY320) were cultivated at 23°C in YP-sucrose. Galactose was then added to induce nondegradable Sic1 and part of the culture was transferred to 37°C for 2.5 h. (b) Localization of Lte1-8N-GFP (MGY409) and Lte1-GFP (SY158) in a cla4Δ background. (c) Cells expressing Lte1-ProA or Lte1-8N-ProA in a WT (MGY261 and MGY415) or a cla4Δ background (MGY443 and MGY444) were arrested with HU and interaction between Lte1 and Ras2 was analyzed by Co-IP. (d) Lte1-8N-ProA purified from cla4Δ (MGY444) cells arrested in HU was treated with phosphatase buffer, with λ-phosphatase alone or in combination with phosphatase inhibitors and analyzed by Western blot. (e) Cells expressing Lte1-3HA and degron Cla4 (MGY313) were cultivated at 25°C and arrested with HU for 2 h. Half of the culture was then transferred at 37°C. Both cultures were sampled at 30-min intervals and Lte1-3HA was analyzed by Western blotting.
Figure 4.Phosphorylated Lte1 interacts with Ras and allows cortical distribution of Lte1. (a) Cells expressing Lte1-ProA (MGY415) were arrested by overexpression of nondegradable Sic1 or by HU treatment, and ProA-tagged proteins were immunoprecipitated. Lte1 (top panels) and Ras2 (bottom panels) were detected in crude extracts (CE) and after Lte1-ProA immunoprecipitation (ProA-IP). (b) Cells expressing Lte1-3HA and a nondegradable Clb2 under the control of GAL1 promoter (MGY239) were cultivated in YP-sucrose and arrested in G1 with α-factor. The culture was split and 2% glucose or galactose was added while the arrest was maintained. Cells were harvested at the indicated times and Lte1 and Clb2[Δdb] were detected by Western blotting. (c) WT cells expressing Lte1-Cdk-3HA (MGY240) or cla4Δ mutants expressing Lte1-3HA (MGY592) and a nondegradable Clb2 under the control of GAL1 promoter were treated as in b. Lte1 and Clb2[Δdb] were detected by Western blotting. (d) Cells expressing Lte1-GFP from a MET3 promoter and a nondegradable Clb2 under the control of GAL1 promoter (MGY565) were cultivated at 30°C in minimal medium without methionine and 2% sucrose. Cells were arrested in G1 with α-factor and localization of Lte1 was observed after 90 min (time 0). Then the culture was split and 2% glucose or galactose was added while the arrest was maintained. Lte1 localization was observed after 90 min. The percentage of cells with indicated Lte1-GFP distribution is indicated (n > 120). (e) Cells treated as in b were harvested after 60 min of addition of glucose or galactose and Lte1-HA was immunoprecipitated. Co-immunoprecipitated Ras2 and Lte1-HA were detected by Western blotting.
Figure 5.Lte1-8N constantly binds to Ras and interferes with its activity. (a) Cells expressing Lte1-ProA (MGY277) and Lte1-8N-ProA (MGY446) were arrested in α-factor, HU, or by expression of nondegradable Sic1. Lte1-ProA was also expressed in cla4Δ cells (MGY567) arrested in HU. ProA-tagged proteins were immunoprecipitated and Lte1 (top panels) and Ras2 (bottom panels) were detected in crude extracts (CE) and after Lte1-ProA immunoprecipitation (ProA-IP). Cells expressing untagged Lte1 were used as controls. (b) Localization of Lte1-8N-GFP and Kel1-CFP in cells overexpressing nondegradable Sic1 (MGY399). DAPI was used to stain nuclei. Asterisk indicates actively growing bud; triangle indicates nongrowing bud. Bar, 5 µm. (c) Cells expressing Lte1-GFP (SY148) or Lte1-8N-GFP (MGY449) under GAL1 promoter control were spotted on glucose- or galactose-containing medium (top panel). Cells expressing Lte1-8N-GFP alone or in combination with Ras2 (MGY517), both under GAL1 promoter control, were spotted on glucose- or galactose-containing medium (center panel). Cells expressing Lte1-8N-GFP and Lte1-8NR1343E-GFP (MGY527) under GAL1 promoter control were spotted on glucose- or galactose-containing medium (bottom panel). (d) Cells expressing Lte1-GFP (○) and Lte1-8N-GFP (•) under GAL1 promoter control were cultivated in YP-sucrose. 2% galactose was added at time 0 and unbudded cells were counted (n > 200 per point) at the indicated times. Error bars represent SD of three experiments.
Figure 6.Lte1 binds to and negatively regulates Bud1. (a) Cells expressing Lte1-GFP (MGY518), or Lte1-8N-GFP (MGY517) and Ras2, or cells expressing Lte1-8NR1343E-GFP (MGY527) alone under GAL1 promoter control were cultivated in galactose- or glucose-containing medium. Budding scars were visualized by Calcofluor staining. Bar, 5 µm. (b) WT (MGY308), lte1Δ (MGY309), and lte1Δ bud1Δ (MGY498) cells, expressing Kel1-GFP and Spa2-GFP, were treated with nocodazole for 2.5 h. Bar, 5 µm. (c) Quantification of the cells in b (n > 150). Error bars show the SD of three independent experiments. (d) Haploid (MGY309) and diploid (MGY485) lte1Δ cells, expressing Kel1-GFP and Spa2-GFP, were treated with nocodazole for 2.5 h as in b. Percentages of cells with a proximal, distal, or dispersed polarizome are indicated (n > 100). Error bars show the SD of three independent experiments. Bar, 5 µm. (e) lte1Δ bud3Δ cells expressing Kel1-CFP (MGY603) were treated with nocodazole for 2.5 h as in b. Bar, 5 µm.
Figure 7.Interaction between Lte1 and activated Bud1. Cells coexpressing GST (MGY562) or GST-Lte1 (MGY563) and Bud1G12V-HA under GAL1 promoter control were cultivated for 4 h in rich medium containing 2% galactose, HU was added, and cells were cultivated for another 2.5 h. After GST pull-down, bound proteins were eluted with 20 mM reduced glutathione. Total crude extract (CE) and eluted material (GST pull-down) were blotted and stained with α-HA antibody (top panels) or α-GST (bottom panel).
Figure 8.Model for Lte1 phosphorylation and localization. Lte1 is in red and polarizome in green. See text for details.
Yeast strains
| Strain name | Relevant genotype | Source or reference |
| 15D | ||
| SY144 | Derived from 15D; | |
| SY148 | Derived from 15D | |
| SY157 | Derived from 15D | |
| SY158 | Derived from 15D | |
| SY159 | Derived from 15D | |
| SY160 | Derived from 15D | |
| MGY205 | Derived from 15D | |
| MGY212 | Derived from 15D | |
| MGY218 | Derived from 15D | |
| MGY232 | Derived from 15D | |
| MGY239 | Derived from 15D | |
| MGY240 | Derived from 15D | |
| MGY261 | Derived from 15D | |
| MGY277 | Derived from 15D | |
| MGY281 | Derived from 15D | |
| MGY296 | Derived from 15D | |
| MGY302 | Derived from 15D | |
| MGY305 | Derived from 15D | |
| MGY308 | Derived from 15D; | |
| MGY309 | Derived from 15D; | |
| MGY313 | Derived from 15D | |
| MGY319 | Derived from 15D | |
| MGY320 | Derived from 15D | |
| MGY321 | Derived from 15D | |
| MGY340 | Derived from 15D | |
| MGY341 | Derived from 15D | |
| MGY369 | Derived from 15D | |
| MGY370 | Derived from 15D | |
| MGY399 | Derived from 15D | |
| MGY423 | Derived from 15D | |
| MGY409 | Derived from 15D | |
| MGY415 | Derived from 15D | |
| MGY443 | Derived from 15D | |
| MGY444 | Derived from 15D | |
| MGY446 | Derived from 15D | |
| MGY449 | Derived from 15D | |
| MGY465 | Derived from 15D | |
| MGY466 | Derived from 15D | |
| MGY479 | Derived from 15D | |
| MGY480 | Derived from 15D | |
| MGY485 | Derived from 15D | |
| MGY498 | Derived from 15D | |
| MGY503 | Derived from 15D | |
| MGY516 | Derived from 15D | |
| MGY517 | Derived from 15D | |
| MGY518 | Derived from 15D | |
| MGY527 | Derived from 15D | |
| MGY530 | Derived from 15D | |
| MGY533 | Derived from 15D | |
| MGY555 | Derived from 15D | |
| MGY562 | Derived from MGY140; | |
| MGY563 | Derived from MGY140; | |
| MGY565 | Derived from 15D | |
| MGY567 | Derived from 15D | |
| MGY574 | Derived from 15D | |
| MGY583 | Derived from CG378 | |
| MGY584 | Derived from CG378 | |
| MGY589 | Derived from 15D | |
| MGY592 | Derived from 15D | |
| MGY593 | Derived from 15D | |
| MGY594 | Derived from 15D | |
| MGY603 | Derived from 15D |
Plasmids used
| Name | Backbone | Content | Source or reference |
| pLD1 | pMHTGal | ||
| pGal-CLB2[ΔDB] | YIplac211 | A. Amon | |
| pGal-LTE1-GFP | pRS406 | ||
| pcla4-75-degron | T. Yamamoto | ||
| pHP659 | pRS306 | H.O. Park | |
| pMG-Lte1 | pMG1 | This study; | |
| pMH919-GST | pMH919 | This study; | |
| pMH14 | pRS423 | This study; | |
| pKGFP-Lte1 | pKGFP | Last 600 bp of | |
| pKGFP-Kel1 | pKGFP | Last 674 bp of | This study |
| pMG97 | pRS304 | Last 674 bp of | This study |
| pMG52 | YIplac128 | ||
| pMG58 | YIplac128 | ||
| pMG69 | pRS406 | This study | |
| pMG108 | YIplac128 | ||
| pMG110 | pRS306 | Last 947 bp of | |
| pMG119 | YIplac128 | This study | |
| pMG120 | YIplac128 | This study | |
| pMG180 | YIplac128 | ||
| pMG183 | YIplac128 | ||
| pMG184 | YIplac128 | This study | |
| pMG191 | YIplac128 | This study | |
| pMG213 | pRS304 | This study | |
| pMG220 | YIplac128 | This study | |
| pMG221 | YIplac128 | This study | |
| pMG237 | pRS306 | This study | |
| pMG246 | pRS306 | Last 570 bp of | This study |
| pMG247 | YIplac128 | This study |